Home Compare NBIX vs NVT
Stock Comparison · Structural lead, mixed market

Neurocrine Biosciences vs nVent Electric: Which Stock Looks Stronger in 2026?

Neurocrine Biosciences holds the cleaner structural position, with the lead spread across valuation and stability. nVent Electric still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, nVent Electric carries the stronger setup — intact trend against Neurocrine Biosciences's broken trend. That leaves a split case: the structural lead stays with Neurocrine Biosciences, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in valuation, but stability adds another real layer to the result. Neurocrine Biosciences, Inc. leads by 14 points on the overall comparison score.

Trajectory Similarity
0.67
Moderately similar
Peer-set rank: #22
within Neurocrine Biosciences, Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in investment intensity and revenue growth trajectory.

Similarity drivers
investment intensityrevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
NBIX
Neurocrine Biosciences, Inc.
56
Peer-Score
Signal qualityMedium
vs
NVT
nVent Electric plc
42
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: NBIX vs NVT Profitability 32 15 Stability 47 26 Valuation 63 42 Growth 88 100 NBIX NVT
Gap Ranking
#1 Valuation +21
#2 Stability +21
#3 Profitability +17
#4 Growth +12
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for NBIX and NVT Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer NBIXNVT Relative valuation Structural strength

Neurocrine Biosciences, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both look solid on valuation, though Neurocrine Biosciences, Inc. still holds the stronger peer position.
Stability
Neurocrine Biosciences, Inc. sits higher in the group on stability, adding to the overall structural advantage.
Valuation — Dominant Gap
NBIX
63
NVT
42
Gap+21in favour of NBIX

The multiple-based pricing edge comes from a forward P/E that is 10.9 turns lower.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

The lead is built on both valuation and stability — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the NBIX vs NVT comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-stability comparisons

Explore how NBIX and NVT each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.